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ABSTRACT 
Cell assays for high-throughput screening (HTS) of potential drug candidates are 
important tools in the process of drug discovery.  Most cellular assays are currently based 
on 2-D monolayer cell cultures, but 3-D cell cultures could better mimic the in vivo 
characteristics of actual organism tissues. Unfortunately, assays using 3-D culture models 
usually require significant manual manipulation and are therefore not suitable for HTS.  
Research under Dr. Shang-Tian Yang has resulted in a functioning system for high-
throughput 3-D cellular assays using engineered cells to express enhanced green 
fluorescence protein (EGFP) quantifiable through fluorometry.  System improvement to 
allow rapid assessment of cellular events, such as specific gene expression or cell cycle 
progress may be limited by the relatively long persistence of the currently used reporter 
protein in the cells.   
In this study a new fluorescence reporting cell line was established using a 
destabilized EGFP (d4EGFP) expressed in Chinese hamster ovary (CHO) cells.  
Correlating the fluorescence response with cell number for the d4EGFP expressing cell 
line in 2-D assays indicated that the fluorescence expression of d4EGFP may be too low 
for use in reporting cell number in a high-throughput manner.  The fluorescence and cell 
number correlation in 3-D assays indicated that slightly better performance could be 
achieved with the d4EGFP reporter in 3-D but further testing is needed to demonstrate 
whether this improvement would be sufficient.  Future work investigating growth and 
environmental conditions or further genetic modification of the cell line is recommended 
to possibly improve the fluorescence expression.   
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Chapter 1.  Introduction 
 
High-throughput screening (HTS) has become an important tool for drug 
discovery.  The number of potential drug candidates is rapidly increasing and HTS allows 
for the testing of a large amount of potential drug candidates in a short amount of time.  
HTS systems that provide faster and better predictions on the merits of potential 
candidates will provide improved efficiency and lower costs for the discovery of new 
drugs.   
Cellular assay tests are one popular type of HTS but most current cellular assay 
tests are done on a 2-D monolayer cell culture.  However, 2-D cellular assays can 
produce misleading results since much of the functionality of in vivo tissues is lost when 
using a simple 2-D culture.  A solution to this problem is to use 3-D cellular assays which 
are more similar to the actual environment of cells. Unlike in 2-D assays, effects 
including cellular aggregation, diffusion limitation, and differential gene expression can 
be present in 3-D cellular assays and thus are a better approximation of in vivo conditions 
(Mueller-Klieser, 1997).   
Optical reporting using internally expressed reporter proteins such as enhanced 
green fluorescence protein (EGFP) is a popular approach for quantifying cellular changes 
in assay tests.  Such optical reporting systems can assess cell number in 3-D without 
disrupting the growth and are not adversely affected by layering of cells.  To assess rapid 
cellular responses in high-throughput, including changes in protein expression or 
promoter activity, more sensitive optical reporting is needed.  Destabilized EGFP 
(dEGFP) is more rapidly degraded in mammalian cells and thus there is more turnover of 
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fluorescence protein in the cell which could provide the sensitivity in response needed to 
improve HTS cellular assays. 
This research focused on the development of a d4EGFP (t1/2 = 4 hrs) expressing 
Chinese hamster ovary (CHO) cell line.  The expression of d4EGFP was validated 
through fluorescence microscopy and the ability of the fluorescence to quantify cell 
number.  Changes in cell number was assessed for the d4EGFP expressing cells and 
compared to EGFP expressing cells previously developed by the group.  Correlation 
between cell number and fluorescence was assessed in a 2D monolayer culture and in a 
culture using 3D scaffolds.  Fluorescence response over extended cell growth in 2-D was  
compared with cell number change over the growth period.  The effect of toxic agents on 
fluorescence response was also be assessed.  The results showed that fluorescence 
response can be correlated with cell number for d4EGFP expressing cells, though the 
fluorescence intensity per cell was lower than desired in 2-D culture and might not allow 
for accurate determination of changes in cell growth without requiring manual 
manipulation and disturbing cell growth.  Recommendations are made on improving 
fluorescence response and future work is also outlined for assessing the suitability of the 
reporter protein for 3-D assays in this thesis. 
 3
 
Chapter 2.  Literature Review 
 
2.1 Biological assays for HTS 
Biomolecular assays can provide detailed information on the reaction kinetics of 
specific biomolecular interactions (VanWiggeren et al., 2007), but how those interactions 
ultimately affect living organisms can be quite complicated.   In vitro cellular assays can 
show the overall effect of a particular agent even if some of the specificity of the 
biomolecular assay is gone.  Even so, many cellular assay systems fail to capture the 
interactions of different tissues and dynamic changes and even lack many of the features 
of tissues in the body.  In vivo animal models can account for the effects of an agent on 
an entire organism but animal testing is expensive, lacks high-throughput capability, can 
raise moral concerns and still does not produce the same results as the human body.  
Ultimately all of these steps are necessary in the process of identifying new effective drug 
agents, but improvement of earlier less expensive steps can ease the burden of the drug 
discovery process.  One of the shortcomings of cellular assays is due to the fact that most 
current cellular assay tests are done on a 2-D monolayer cell culture.  Unfortunately, 
since much of the functionality of in vivo tissues is lost when using a simple 2-D culture, 
these types of assays often produce misleading results.  Drugs may be effective on a 2-D 
monolayer but ineffective in vivo due to a variety of reasons such as poor penetration into 
solid tissues or differences in native cell morphology and metabolism (Mueller-Klieser, 
1997).  Much money is wasted when successful candidates in 2-D studies are advanced to 
more expensive in vivo animal testing and fail due to differences between 2-D and in vivo 
cellular characteristics (Seiler et al, 2003). 
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A solution to this problem is to use 3-D cellular assays which are more similar to 
the actual environment of cells. Unlike in 2-D assays, effects including cellular 
aggregation, diffusion limitation, and differential gene expression can be present in 3-D 
cellular assays and thus are a better approximation of in vivo conditions (Mueller-Klieser, 
1997).  However, one serious drawback to 3-D assays is that they usually require a 
significant amount of manual manipulation and consequently are not well suited for HTS. 
 
2.2 Green fluorescence protein (GFP) based optical reporting  
 It is difficult to assess cells number in 3-D without disrupting the growth.  Optical 
reporting methods using internally expressed reporter proteins can offer a solution to this 
problem.  One such reporter protein is green fluorescence protein (GFP).  GFP was 
originally isolated from Aequorea jellyfish by Shimomura et al. (1962) and is now a 
popular reporter protein for biological research (Arun et al., 2005).  Unlike other optical 
reporter systems currently available such as luciferase and β-galactosidase, GFP does not 
require the addition of substrates which reduces the manual manipulation involved and 
improves the potential for high-throughput application (Yang et al., 1993; Zhang et al. 
1996).  GFP fluoresces naturally due to the light-emitting chromophore within the 
primary amino acid sequence (Arun et al. 2005).  The chromophore is a cyclic tripeptide 
consisting of Ser-Tyr-Gly at positions 65-67 and requires a cyclization reaction and an 
oxidation step at the Tyr66 to form (Arun et al., 2005).  The chromophore is contained in 
a central α-helix enclosed in a tightly packed β-can structure (Arun et al., 2005).  Amino 
acids 7-229 of the 238 amino-acid protein are necessary for fluorescence (Arun et al., 
2005). A number of variants to wild-type GFP (wt-GFP) have been developed which 
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broaden the uses of GFP.  Red-shifted variants including enhanced green fluorescence 
protein (EGFP) have an excitation peak shifted closer to the wavelength emitted by lasers 
commonly used with fluorescence-activated cell sorting (FACS) devices and confocal 
scanning laser microscopes (Arun et al., 2005).  EGFP also features a 4-35 fold increase 
in fluorescence intensity as compared to wt-GFP, due to a double amino acid substitution 
[Phe-64 to Leu and Ser-65 to Thr] (Arun et al., 2005).  Both the shift to a more desirable 
excitation peak as well as the increased fluorescence make EGFP highly suited for use as 
a reporter protein for cellular assays. 
 
2.3 Successful HTS 3-D cell assay system using EGFP 
 Our research group has made significant strides in the development and 
optimization of a HTS 3-D cellular assay system (Zhang et al. 2005; Zhang, Wen et al. 
2007; Zhang, Ng et al. 2007, Zhang, 2008).  A HTS system using genetically modified 
embryonic stem (ES) cells expressing EGFP cultured in 3-D fibrous scaffolds was 
developed.  This system only required manual manipulation at initiation and cell number 
can be determined automatically using fluorometry through the whole experiment due to 
the stable expression of EGFP.  This system has been shown to effectively monitor cell 
growth kinetics, and has produced cytotoxicity results consistent with other results in 
literature and clinical trials (Zhang, 2008; Smitskamp-Wilms et al., 1998).  Planned 
improvement for the system includes extending the system to be able to assess rapid 
cellular responses. However, the current fluorescence protein being used (EGFP) has a 
half life of over one day and may not be well suited for this purpose as changes in 
fluorescence may not occur fast enough. 
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2.4 Current work with destabilized EGFP 
 As discussed by Kain (1999) variants of GFP called destabilized EGFP (dEGFP) 
have been engineered to by fusing a PEST amino acid sequence, enriched in proline (P), 
glutamic acid (E), serine (S) and threonine (T), to the C-terminus of EGFP (Rechsteiner, 
1996).  As a result of the PEST sequence proteolysis of the protein by a 26S proteosome 
is expedited in mammalian cells.  Variants d1EGFP, d2EGFP and d4EGPF exist, formed 
through mutagenesis of the PEST sequence, and have half lives of one, two and four 
hours respectively, as compared to over 24 hrs for EGFP.  Though the half lives are 
different, the spectral properties of the dEGFP variants are the same as for EGFP since 
amino acids 7-229 which are needed for fluorescence remain unchanged from EGFP.  
These variants have been used as an alternative to EGFP when changes in protein 
expression or promoter activity are variables of interest.  (Kain, 1999)   
 Because dEGFP is more rapidly degraded there is more turnover of fluorescence 
protein in the cell.  When cells are growing, increases in fluorescence should be more 
closely associated with the change in cell number and not the accumulation of 
fluorescence protein in existing cells.  When cells are exposed to a toxic agent that 
reduces protein expression or kills the cell, the fluorescence response should be faster 
since accumulated protein will be degraded more quickly.  
 The dEGFP variants have already been used for their more sensitive response.  
Proteasome activity has been monitored in a mouse neuroblastoma cell line using a 
constitutively expressed d2EGFP reporter by Nahreini et al. (2003).  Significant increases 
in fluorescence were observed in response to proteasome inhibition after 24 hrs as 
determined from flow cytometry (Nahreini et al., 2003).  The d4EGFP variant has also 
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been used to test the transcriptional activity of synthetic mammalian promoters for HiB5, 
ARPE-19, and CD8+ T cell lines (Tornøe et al., 2002; Cooper et al., 2004).  After cell 
transfection with d4EGFP under the control of various promoters, differences in 
fluorescence levels as determined using flow cytometry were used to indicate the relative 
transcriptional activity of the different promoters.  Though these works support the use of 
dEGFP for specific protein and transcription activity analysis, they do not feature the use 
of dEGFP in high-throughput since flow cytometry requires sample preparation and 
disturbs cell growth.   
 The d2EGFP variant has also been used to monitor specific gene expression 
pathway activity (Ullerås et al., 2005).  A d2EGFP reporting system with the reporter 
under the control of a cytokine promoter in mouse immune system cells has shown 
d2EGFP-mediated fluorescence change in a dose dependent fashion following exposure 
to xenobiotics to induce or inhibit cytokine expression as determined using fluorescence 
microscopy and flow cytometry (Ullerås et al., 2005).  Khan et al. (2006) used an 
expression vector encoding an in-frame fusion of d4EGFP with the human Bid protein, a 
pro-apoptotic protein, to monitor protein translocation using fluorescence microscopy.  
Localized intracellular fluorescence was seen in images from microscopy indicating 
where the Bid protein resides in the cell (Khan et al., 2006).   King et al. (2007) studied 
dynamic, promoter induced changes in protein expression using d4EGFP and d2EGFP 
under the control of various inducible promoters.  Fluorescence was monitored 
automatically every 90 minutes using quantitative fluorescence microscopy and the 
resultant fluorescence profiles had reasonable consistency with expected promoter 
induction characteristics (King et al., 2007). The use of fluorescence microscopy in 
 8
assessing fluorescence response has more potential for high-throughput capability as it is 
not necessary to disturb cell growth, but is expensive if quantitative results are desired 
and cannot provide rapid results for a large number of samples (Haney et al., 2006).  
 Hansen et al. (2002) have used d2EGFP under the control of a NF-κB 
transcription factor to show redox-sensitive transcription changes.  In their system, 
fluorometry was used to quantify fluorescence but only after centrifugation and 
freeze/thawing of the cells (Hansen et al., 2002).  Though the fluorescence response was 
measured using fluorometry, which is highly suited for high-throughput applications, 
manual sample preparation and steps disturbing cell growth were still performed and it is 
unclear whether suitable fluorescence response could have been obtained directly without 
such manipulation which would be more desirable for high-throughput.   
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Chapter 3.  Materials and Methods 
 
3.1 Cell maintenance 
 CHO cells were maintained in T-flasks using a 1:1 ratio of Ham's F-12 Medium 
and Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) with 5% fetal bovine serum 
(FBS, Gibco), 5% CDM4CHO, 1% glutamine, and 0.2% MTX. 
 
3.2 Transfection and clonal isolation 
 
 The plasmid vector pd4EGFP-N1 (Clontech, Palo Alto, CA) was used which 
features the d4EGFP gene under the control of a human cytomegalovirus (CMV) 
promoter, a strong constitutive promoter with expression levels not varying much due to 
environmental effects. The plasmid was transfected into CHO cells using Lipofectamine 
(Invitrogen).  To perform the transfection the cells were plated into a 12 well plate and 
allowed to grow to roughly 70% confluence.  At that point the regular growth medium 
was replaced with 500 μL FBS free medium and incubated for 1 hour.  Lipofectamine 
and the plasmid were added to separate containers of 500 μL FBS free medium for a final 
concentration of 2 µg/ml for each.  The Lipofectamine and plasmid solutions were 
combined after 5 minutes and then pipetted over the cells after 20 minutes.  The medium 
was then replaced with growth medium after 4-6 hours.   Once cells had reached 
confluence, further amplification was done in a small t-flask.  When cells had reached 
70% confluence, fluorescence positive cells were selected using FACSCalibur (BD, CA).  
Cells were amplified again and then cultured in a 96 well plate (BD OptiluxTM, 
Black/clear bottom) at a concentration of 1-2 cells per well.  After amplification, wells 
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with a single fluorescent colony and no non-fluorescent colonies were selected using a 
fluorescence microscope.  Those cell lines were amplified and put in cold storage in 5% 
DMSO, 40% FBS, and 55% growth medium.   
 
3.3 Fluorescence signal and cell number correlation in 2-D 
 For both d4EGFP and EGFP expressing cell lines cells were amplified in several 
25-cm2 T-flasks then trypsinized, centrifuged and re-suspended in growth medium.  Cell 
concentration was determined with a hemocytomter and known amounts of cells (0, 0.5, 
1, 2, and 4 million cells) were added to wells of a 96 well plate and suspended in 180 μL 
of growth medium.  Fluorescence intensity was then measured with a Cytofluor Series 
4000 from Applied Biosystems, Foster City, CA (excitation at 485nm with a bandwidth 
of 20 nm and emission at 530 nm with a bandwidth of 25 nm). 
 
3.4 Fluorescence signal and cell number correlation in 3-D 
 Following the method of Zhang (2008), 3D culture scaffolds were made from 
hole punched polyethylene terephtalate (PET) fabric (fiber diameter, ~20 μm; fiber 
density 1.35 g/cm3, 0.1 cm height, 0.3 cm2 bottom surface area).  Scaffolds were added to 
a solution of 1% (w/v) Na2CO3 and 1% (v/v) Tween-20, heated to 60oC and left to soak 
for 30 min.  Scaffolds were rinsed with distilled water and then boiled in a 1% NaOH 
solution for 30 min.  After being washed again scaffolds were soaked in PBS and 
sterilized in an autoclave at 121oC for at least 20 minutes.  The sterilized scaffolds were 
then stored at room temperature prior to use.  Before use scaffolds were soaked in 10 
μg/ml fibronectin for 12 hours and then in growth medium for 12 hours.  Growth medium 
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was removed and for both d4EGFP and EGFP expressing cells 25 μl of known amount of 
cells (0.06, 0.12, 0.25 and 0.50 million cells) were seeded onto each scaffold.  After 6 
hours, 180 μL of medium was added to each plate and the fluorescence was measured. 
 
3.5 Growth kinetics 
 EGFP and d4EGFP expressing cells were plated in multiple 25 cm2 T-flasks, 6 
well plates, as well as in a 96 well plate.  Over 5 days fluorescence measurements were 
taken from the 3 sources and cells were counted from wells of the 96 well plate using a 
hemocytometer.  For each sample, the cells from one T-flask for d4EGFP and one well of 
the 6 well plates for d4EGFP and EGFP were removed and suspended in 180 μL of either 
medium or PBS in the 96 well plate.  For both the d4EGFP and the EGFP cell lines one 
of the wells in the 96 well plate had its medium replaced with PBS and then the 
fluorescence of all wells was measured.  Afterwards, a sample was taken from one of the 
wells for EGFP and d4EGFP and the number of cells was counted using a 
hemocytometer.   
 
3.6 2-D toxicity in PBS suspension 
 EGFP and d4EGFP expressing cells were added to a 96 well plate suspended in 
180 μL of PBS at a concentration of 0.5 million cells per well.  Either etoposide (Sigma) 
or doxorubicin (Sigma) was added to wells at a final concentration of either 10 μg/mL or 
50 μg/mL.  The fluorescence signal was measured continuously over 4 hours. 
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3.7 2-D toxicity with anchored cells 
 Ten thousand d4EGFP expressing cells were added to wells of a 96 well plate in 
180 μL of growth medium and incubated for 12 hours.  Drug was added to wells at a final 
concentration of 50 μg/mL.  The drugs used were etoposide, doxorubicin, and 5-
fluorouracil (Sigma).  The fluorescence signal was measured continuously over 4 hours.   
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Chapter 4.  Results and Discussion 
 
4.1 Transfection and clonal isolation 
 The plasmid transfection efficiency was consistently around 10% as determined 
via fluorescence microscopy.  After allowing the cells to amplify for until close to 100% 
confluence was achieved in a 25-cm2 T-flask, the percentage of cells with detectable 
fluorescence had decreased to roughly 1% possibly indicating that genomic integration of 
the plasmid had not occurred in a majority of the positively transfected cells.  Cells were 
sorted using FASC with 0.8% positive events.  Cells were amplified again and around 
10% of cells had positive fluorescence; however, the intensity of fluorescence was less 
than immediately after transfection.  After plating 1-2 cells in each well of a 96 well plate 
and amplifying for 10 days wells were selected that had a single fluorescence-positive 
colony and no fluorescence-negative colonies.  The cells in wells meeting these criteria 
were amplified and determined to be stably fluorescing after many passages by 
fluorescence microscopy (see Figure 1).   
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Figure 1. The clonal cell line established exhibits fluorescence after many passages.  The 
intensity differs among cells which may be due to differences in expression at different 
cell phases.   
 
 
4.2 Fluorescence signal and cell number correlation 
 In both a medium suspension and in 3D scaffolds fluorescence had a statistically 
significant correlation (at α = 0.5) with number of cells for both d4EGFP and EGFP 
expressing cells (see Figure 2).  It was expected, based on the differences in half lives and 
assuming similar expression levels, that around 6 times more fluorescence protein would 
accumulate in each cell for EGFP as compared to d4EGFP.  However, in medium 
suspension, the slope of the fluorescence with respect to the EGPF expressing cell 
number was 10.7 times higher than the slope with respect in the d4EGFP expressing cell 
number.  The discrepancy from the expected 6-fold difference to the observed 10.7-fold 
difference could indicate that the expression level of the d4EGFP cell line is lower than 
that of the EGFP cell line.   
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A 
 
B 
 
Figure 2. In both the 2-D culture (A) and in the 3D scaffolds (B), the fluorescence varies 
linearly with number of cells.   
 
 
The slopes with 3-D scaffolds were higher than those in suspension, a result obtained in 
previous work in the group (Zhang, 2008); however, this effect was less pronounced than 
previously observed. There was a 2.4 times steeper slope from 3-D scaffolds to medium 
suspension for EGFP expressing cells and a 1.3 times steeper slope for d4EGFP 
expressing cells.   
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 The slope obtained from the fluorescence versus cell number indicated that the 
change in cell number needed to have a change in fluorescence response ~5 units for the 
2-D culture would be 10000 cells for d4EGFP and 1000 cells for EGFP.  To get the same 
change in fluorescence response in 3-D would require a change in cell number of around 
7000 cells for d4EGFP and 400 cells for EGFP. 
 
 
Figure 3. Fluorescence over time had little variation for d4EGFP cells in the 96 well 
plate.  Fluorescence over time had a higher variation for EGFP and for d4EGFP in larger 
quantities (6 well plate and T-flask). 
 
 
4.3 Growth kinetics 
 The change in fluorescence response over the course of the growth kinetics 
experiment is summarized in Figure 3.  The d4EGFP expressing cells had a low range of 
fluorescence response in the 96 well plate, with EGFP expressing cells in the 96 well 
plate having around 20 times the range of response.  The difference in response range is 
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due in part to the difference in cell growth (see Figure 4).  The range in cell number count 
of EGFP expressing cells was about 4 times that of d4EGFP expressing cells.  The 
fluorescence range for d4EGFP cells from the 6 well plate and from the T-flask were 
higher and could show a change in cell number more clearly; however, this required 
removing the cells from their source, centrifuging and placing them in a 96 well plate to 
measure the fluorescence.   
  
 
 
Figure 4. The overall change in cell number for the d4EGFP expressing cells was lower 
than that of the EGFP expressing cells.  The d4EGFP expressing cells decreased in 
number more quickly than the EGFP expressing cells. 
 
 
The fluorescence response from the 96 well plate is compared with the cell count from 
the 96 well plate in Figure 5.  At an alpha level of 0.05, the fluorescence response had a 
significant correlation with cell count for the EGFP expressing cells in medium (p=0.03), 
but not for EGFP in PBS (p=0.13), d4EGFP in medium (p=0.92) or d4EGFP in PBS 
(p=0.31).  The EGFP cells had a closer correlation between cell number and fluorescence 
than the d4EGFP cells.  For EGFP the slopes of the fluorescence versus cell number were 
higher than predicted from the fluorescence and cell number correlation experiment.  For 
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d4EGFP the slope was similar to what the previous experiment predicted but was too low 
to have a significant change in fluorescence. 
 
 
A 
 
B 
 
Figure 5. The correlation between fluorescence and cell number for d4EGFP expressing 
cells (A) and EGFP expressing cells (B).  EGFP cells had a better overall correlation 
(higher R2) and a larger relative response (slope of line). 
 
4.4 2-D toxicity in PBS suspension 
 The toxicity experiment indicated that the fluorescence changes in response to 
drug addition (Figure 6).  An unexpected result was the increase in fluorescence that was 
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observed initially with EGFP expressing cells and during two periods with d4EGFP 
expressing cells.  It is suspected that this might be due to recovery from photobleaching 
or oxidation of the fluorescence proteins.  The trend of fluorescent response is as 
expected, with fluorescence response changing due to drug exposure in a dose dependent 
manner.  The response is more discernable with the EGFP expressing cells than with the 
d4EGFP expressing cells.   
 
A 
 
B 
 
Figure 6. The change in fluorescence response for EGFP expressing cells (A) and 
d4EGFP expressing cells (B) was highest with no drug and lower with drug, with the 
most reduced scaled response for etoposide at 50 μg/ml. 
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4.5 2-D toxicity with anchored cells 
 In a second toxicity test cells were assayed in both PBS and medium as shown in 
Figure 7.  As occurred with the growth kinetics experiment the cells in medium had a 
larger magnitude of fluorescence change than the cells in PBS indicating that the cells’ 
interaction with the medium affects the fluorescence along with the d4EGFP.  For the 
trials performed in medium the fluorescence response was similar for each drug and 
depressed the fluorescence as compared with wells with no drug added.  For the trials in 
PBS the fluorescence change was positive and was roughly the same for all trials with the 
doxorubicin trial having a slightly lower change.  It is possible that the drug does not act 
quickly enough on the cells to result in a significant change in fluorescence which would 
be why there was not a significant difference in fluorescence change due to the addition 
of drug. 
 
 
 
 
 
 
 
 
 
 
 21
 
A 
 
B 
 
Figure 7. The fluorescence change observed with cells suspended in medium (A) was 
similar with all the drugs used and was lower than with no drug.  The fluorescence 
change with cells suspended in PBS was similar for all treatments with the exception of a 
slightly lower change with doxorubicin.   
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Chapter 5.  Conclusions and Recommendations 
 
 The d4EGFP expressing cell line may not be suited for high-throughput screening 
from 2-D culture using fluorometry due to the low intensity of fluorescence per cell.  
Fluorescence per cell for 3-D was slightly improved from 2-D but more work is needed 
to determine whether the cell line can suitably report fluorescence for high-throughput 3-
D cellular assays.  Since previous work has shown that higher cell densities can be 
obtained in 3-D culture it is still possible that the cell line will be able to have a 
significant enough fluorescence change in response to changes in cell number.  Growth 
kinetic experiments using the 3-D culture would shed light on this feasibility.  
 Since some of the fluorescence changes were not as expected for the experiments, 
future work should also consider the effect of environmental factors such as 
photobleaching, oxygen levels, pH and temperature to determine whether fluorescence 
might have been affected in some unexpected way by such factors.  If such factors do 
significantly affect fluorescence then they might be able to be better controlled for future 
experiments and allow for better results. 
 If ultimately the d4EGFP expressing cell line proves unsuitable for cell number 
reporting, then there is still a possibility that future transfection attempts could yield a 
cell line with higher fluorescence expression.  It may be that the location of the plasmid 
insert is responsible for the low levels of fluorescence expression.  Future transfection 
experiments might yield cell lines with gene inserts in a region with higher expression.  
Also, it is possible that the current cell line could be transfected again and sorted by 
fluorescence intensity to yield a cell line that has multiple copies of the fluorescence 
protein gene and would thus have improved expression. 
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